Sarepta Therapeutics, Inc. SRPT Change in Deferred Revenue
Change in Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInDeferredRevenue.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s change in deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s change in deferred revenue?
- Sarepta Therapeutics, Inc. (SRPT) reported change in deferred revenue of -$274.92M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s change in deferred revenue changed year-over-year?
- Sarepta Therapeutics, Inc.'s change in deferred revenue decreased by 221.9% year-over-year, from -$85.4M to -$274.92M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s change in deferred revenue?
- Over 3 years (2021 to 2025), Sarepta Therapeutics, Inc.'s change in deferred revenue has grown at a -6.9% compound annual growth rate (CAGR), from -$89.24M to $72.05M.
- What does change in deferred revenue mean?
- Change in payments received from customers for goods/services not yet delivered — a key SaaS and subscription metric.